Sensei Biotherapeutics Inc
(NAS:SNSE)
$
0.4792
0.0251 (5.53%)
Market Cap: 11.42 Mil
Enterprise Value: -31.11 Mil
PE Ratio: 0
PB Ratio: 0.25
GF Score: 29/100 Sensei Biotherapeutics Inc at Citi Virtual Oncology Leadership Summit Transcript
Feb 23, 2023 / 04:00PM GMT
Release Date Price:
$1.62
(+10.96%)
Sam Semenkow
Citigroup Inc. - Analyst
Good morning, everyone, and welcome to this session of Citi's Virtual Oncology Leadership Summit. I am Sam Semenkow, one of the biotech analysts here at Citi.
And today, it's my pleasure to host Sensei Biotherapeutics. I'd like to welcome John Celebi, President and Chief Executive Officer at Sensei and Edward van der Horst, Chief Scientific Officer at Sensei. John and Edward, thank you for being here.
John Celebi
Sensei Biotherapeutics, Inc. - President & CEO
Thank you, Sam. Thanks for hosting us.
Edward van der Horst
Sensei Biotherapeutics, Inc. - Chief Scientific Officer
Thank you.
Sam Semenkow
Citigroup Inc. - Analyst
Yeah, so just a note to those listening live, if you have any questions for John and Edward during the session, please send them to my e-mail at [email protected], and I'll be happy to ask them on your behalf. So with that, John, if you could start us off with just a brief overview of the
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot